Table 1.
Positive symptoms | Negative symptoms* |
---|---|
Unspecific: Present in the general population (continuum) and in psychiatric diagnosis at large, being a marker of severity | Present to a minor extent in some psychiatric diagnosis; far more related to schizophrenia |
Dopaminergic (D2) dysfunction observed all accross the phenotipic continuum of psychosis | Serotonine, acetyl-choline, and mainly glutamate dysfunction. May affect dopamine receptors (D1, D3, D4) |
Temporal lobe, limbic areas | Frontal and prefrontal cortex |
Amenable to adaptation, generally responsive to antipsychotics | Insidious onset, enduring, do not respond to medication, generates disability |
More evident, draw physician’s and public attention, related to stigma | Furtive, may progress unnoted, less related to stigma |
Generally do not predict outcome in schizophrenia | Related to worse outcome in schizophrenia |
*Primary negative symptoms, not including secondary negative symptoms.